Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-05-06
1995-04-18
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514335, 546256, 546261, C07D40114, C07D40110, A61K 3144, A61K 3153
Patent
active
054079489
ABSTRACT:
Substituted mono- and bipyridylmethylpyridones are prepared either by reaction of pyridones with mono- or bipyridylmethylhalogen compounds or by reaction of pyridone-substituted halogenopyridines with tetrazolylphenylboronic acids. The substituted mono- and bipyridylmethylpyridones can be employed as active compounds in medicaments, in particular for the treatment of arterial hypertension and atherosclerosis.
REFERENCES:
patent: 5128327 (1992-07-01), Chakravarty et al.
patent: 5149699 (1992-09-01), Ellingboe et al.
The Journal of Cell Biology, vol. 50, 1971, pp. 172-186; "The Smooth Muscle Cell", R. Ross.
Beuck Martin
Bischoff Hilmar
Denzer Dirk
Dressel Jurgen
Fey Peter
Bayer Aktiengesellschaft
Davis Zinna N.
Ivy C. Warren
LandOfFree
Substituted mono- and bipyridylmethylpyridones does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted mono- and bipyridylmethylpyridones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted mono- and bipyridylmethylpyridones will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-67542